tiprankstipranks

ROBERTO MIGNONE Insider Profile

4 Followers
ROBERTO MIGNONE, Director at Teva Pharmaceutical, holds 1.08M shares in Teva Pharmaceutical (Ticker: TEVA), holds ― shares in Guardant Health (Ticker: GH). Most recently, ROBERTO MIGNONE Sold ― shares of Teva Pharmaceutical on Jun 21, 2024 for an estimated value of 8.84M.
tipranks
ROBERTO MIGNONE

ROBERTO MIGNONE
Teva Pharmaceutical (TEVA)
Director

Ranked #60,822 out of 99,335 Corporate Insiders

Profitable Transactions

0%
0 out of 2 Profitable Transactions

Average Return

-13.20%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$18M
100.00%
0.00%
A breakdown of ROBERTO MIGNONE's holdings

Insider Roles

Teva Pharmaceutical
(TEVA)
Director
Guardant Health
(GH)
Director
Roles that ROBERTO MIGNONE holds in companies

Most Profitable Insider Trade

Stock:
Teva Pharmaceutical
(TEVA)
Rating:Informative Sell
Date:Jun 21, 2024 - Today
Return:-0.80%
The most profitable trade made by ROBERTO MIGNONE

ROBERTO MIGNONE's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Teva Pharmaceutical
Jun 21, 2024
Director
Informative Sell
8.84M
$18.34M
Guardant Health
Director
List of latest transactions for each holding click on a transaction to see ROBERTO MIGNONE's performance on stock

ROBERTO MIGNONE insider profile FAQ

What is the percentage of profitable transactions made by ROBERTO MIGNONE?
The percentage of profitable transactions made by ROBERTO MIGNONE is 0%.
    What is the average return per transaction made by ROBERTO MIGNONE?
    The average return per transaction made by ROBERTO MIGNONE is -13.20%.
      What stocks does ROBERTO MIGNONE hold?
      ROBERTO MIGNONE holds: TEVA, GH stocks.
        What was ROBERTO MIGNONE’s latest transaction?
        ROBERTO MIGNONE latest transaction was an Informative Sell of $8.84M.
          What was ROBERTO MIGNONE's most profitable transaction?
          ROBERTO MIGNONE’s most profitable transaction was an Informative Sell of TEVA stock on June 21, 2024. The return on the trade was -0.80%.
            What is ROBERTO MIGNONE's role in Teva Pharmaceutical?
            ROBERTO MIGNONE's role in Teva Pharmaceutical is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.